Tempest Therapeutics
TPST
#10989
Rank
โ‚ฌ6.93 M
Marketcap
0,35ย โ‚ฌ
Share price
-0.29%
Change (1 day)
-95.70%
Change (1 year)

EPS for Tempest Therapeutics (TPST)

EPS in 2026 (TTM): -4,91ย โ‚ฌ

According to Tempest Therapeutics's latest financial reports the company's current EPS (TTM) is -5,20ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -5,75ย โ‚ฌ an increase over its 2024 EPS that were of -17,70ย โ‚ฌ.

EPS history for Tempest Therapeutics from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-4,91ย โ‚ฌ-14.49%
2025-5,75ย โ‚ฌ-67.54%
2024-17,70ย โ‚ฌ-21.47%
2023-22,54ย โ‚ฌ-38.19%
2022-36,46ย โ‚ฌ-58.63%
2021-88,15ย โ‚ฌ158.05%
2020-34,16ย โ‚ฌ